HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshifumi Ninomiya Selected Research

Collagen Type IV (Type IV Collagen)

3/2013Differential expression of basement membrane type IV collagen α2 and α6 chains as a prognostic factor in patients with extrahepatic bile duct carcinoma.
1/2011Clonal overgrowth of esophageal smooth muscle cells in diffuse leiomyomatosis-Alport syndrome caused by partial deletion in COL4A5 and COL4A6 genes.
2/2008The expression of type IV collagen alpha6 chain is related to the prognosis in patients with esophageal squamous cell carcinoma.
3/2006Loss of expression of type IV collagen alpha5 and alpha6 chains in colorectal cancer associated with the hypermethylation of their promoter region.
11/2005Regulation of collagen type IV genes is organ-specific: evidence from a canine model of Alport syndrome.
7/2004High nephritogenicity of monoclonal antibodies belonging to IgG2a and IgG2b subclasses in rat anti-GBM nephritis.
7/2004Differential expression of basement membrane type-IV collagen alpha1, alpha2, alpha5 and alpha6 chains among the histological subtypes of adenoid cystic carcinoma.
7/2004DDR1-deficient mice show localized subepithelial GBM thickening with focal loss of slit diaphragms and proteinuria.
3/2003Immunohistochemical diagnosis of Alport's syndrome in paraffin-embedded renal sections: antigen retrieval with autoclave heating.
9/2002Distribution of collagen type IV alpha1-6 chains in human normal colorectum and colorectal cancer demonstrated by immunofluorescence staining using chain-specific epitope-defined monoclonal antibodies.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshifumi Ninomiya Research Topics

Disease

13Neoplasms (Cancer)
05/2014 - 01/2002
7Infarction (Infarctions)
12/2005 - 05/2002
5Chondrosarcoma
03/2009 - 01/2002
5Myocardial Infarction
12/2005 - 05/2002
4Inflammation (Inflammations)
02/2014 - 11/2008
4Arthritis (Polyarthritis)
02/2014 - 05/2005
4Hereditary Nephritis (Alport Syndrome)
11/2005 - 10/2002
3Colorectal Neoplasms (Colorectal Cancer)
03/2006 - 03/2002
3Ischemia
12/2005 - 01/2003
2Carcinogenesis
04/2016 - 01/2002
2Hepatocellular Carcinoma (Hepatoma)
04/2016 - 11/2004
2Gliosis
06/2013 - 04/2004
2Atherosclerosis
07/2011 - 07/2010
2Insulin Resistance
07/2011 - 07/2010
2Hypoxia (Hypoxemia)
01/2011 - 06/2009
2Hypertrophy
12/2010 - 01/2009
2Cold Injury
05/2010 - 04/2004
2Head and Neck Neoplasms (Head and Neck Cancer)
06/2009 - 08/2005
2Hemorrhage
05/2008 - 07/2004
2Glomerulonephritis
07/2004 - 02/2004
1Spinal Cord Injuries (Spinal Cord Injury)
06/2013
1Mitochondrial Diseases (Mitochondrial Disease)
05/2013
1Carcinoma (Carcinomatosis)
03/2013
1Hypertension (High Blood Pressure)
07/2011
1Essential Hypertension
07/2011
1Leiomyoma (Uterine Fibroids)
01/2011
1Fibrosis (Cirrhosis)
12/2010
1Brain Injuries (Brain Injury)
05/2010
1Rheumatoid Arthritis
01/2010
1Osteoarthritis
01/2010
1Neoplasm Metastasis (Metastasis)
06/2009
1Necrosis
04/2009
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2009
1Esophageal Squamous Cell Carcinoma
02/2008
1Atrial Fibrillation
02/2008
1Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
02/2008
1Atrioventricular Block
06/2007
1Syncope (Fainting)
06/2007
1Coronary Artery Disease (Coronary Atherosclerosis)
06/2007
1Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
07/2006

Drug/Important Bio-Agent (IBA)

12Messenger RNA (mRNA)IBA
05/2010 - 05/2002
11Collagen Type IV (Type IV Collagen)IBA
03/2013 - 03/2002
8CollagenIBA
04/2016 - 04/2002
5Proteins (Proteins, Gene)FDA Link
12/2010 - 01/2003
3Metalloproteases (Metalloproteinases)IBA
06/2013 - 10/2004
3DisintegrinsIBA
06/2013 - 10/2004
3ThrombospondinsIBA
06/2013 - 10/2004
3Collagen Type XVIII (Type XVIII Collagen)IBA
05/2013 - 04/2002
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2010 - 05/2005
3Monoclonal AntibodiesIBA
11/2004 - 09/2002
3AntibodiesIBA
07/2004 - 01/2002
2Liposomes (Liposome)IBA
02/2014 - 11/2008
2IntegrinsIBA
05/2013 - 04/2002
2Fatty Acid-Binding ProteinsIBA
07/2011 - 07/2010
2olmesartanIBA
07/2011 - 12/2010
2Thrombospondin 1IBA
05/2010 - 10/2005
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2009 - 01/2002
2Matrix Metalloproteinases (MMPs)IBA
06/2009 - 10/2004
2Interleukin-1beta (Interleukin 1 beta)IBA
03/2009 - 05/2005
2Aggrecans (Aggrecan)IBA
01/2009 - 05/2005
2EndostatinsIBA
11/2004 - 04/2002
2Peptides (Polypeptides)IBA
11/2004 - 09/2002
2Collagen Type I (Type I Collagen)IBA
07/2003 - 11/2002
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
05/2002 - 01/2002
2Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
04/2002 - 01/2002
1Gold Colloid (Colloidal Gold)IBA
02/2014
1aggrecanaseIBA
06/2013
1Proteoglycans (Proteoglycan)IBA
06/2013
1Chondroitin Sulfate ProteoglycansIBA
06/2013
1Peptide Hydrolases (Proteases)FDA Link
06/2013
1Cyclosporine (Ciclosporin)FDA LinkGeneric
05/2013
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
05/2013
1Losartan (Cozaar)FDA LinkGeneric
05/2013
1LDL CholesterolIBA
07/2011
1Angiotensin II Type 1 Receptor BlockersIBA
07/2011
1Triglycerides (Triacylglycerol)IBA
07/2011
1Androgen Receptors (Androgen Receptor)IBA
01/2011
1Green Fluorescent ProteinsIBA
01/2011
1Hydralazine (Apresoline)FDA LinkGeneric
12/2010
1Connective Tissue Growth FactorIBA
12/2010
1Histone Deacetylases (Histone Deacetylase)IBA
01/2010
1Histone Deacetylase 1IBA
01/2010
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
06/2009
1ChromatinIBA
06/2009
1MetalsIBA
06/2009
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
06/2009
1LuciferasesIBA
06/2009
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
06/2009
1Hyaluronan ReceptorsIBA
01/2009
1Hyaluronic Acid (Hyaluronan)IBA
01/2009
1Sialyl Lewis X AntigenIBA
11/2008
1Fibronectins (Fibronectin)IBA
05/2008
1Betamethasone (Celestone)FDA Link
05/2008
1Brain Natriuretic Peptide (Natrecor)FDA Link
02/2008
1Small Interfering RNA (siRNA)IBA
02/2008
1Thallium-201IBA
06/2007
1Adenosine (Adenocard)FDA LinkGeneric
06/2007
1Telomerase (Telomerase Reverse Transcriptase)IBA
09/2006
1Conditioned Culture MediaIBA
09/2006

Therapy/Procedure

3Therapeutics
05/2014 - 01/2002